US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 0.1338
  • -0.0313-18.96%
Close Nov 22 16:00 ET
  • 0.1346
  • +0.0008+0.60%
Post 19:57 ET
25.85MMarket Cap-557P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.061M--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.061M--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Citius Pharmaceuticals Earnings Reports

  • 8-K: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update

    Aug 12 17:27 ET

  • 10-Q: Q3 2024 Earnings Report

    Aug 12 16:56 ET

  • 10-Q: Q2 2024 Earnings Report

    May 14 16:43 ET

  • 8-K: Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update

    May 14 16:32 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 22, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data